Haemonetics Corporation (HAE)
Operating return on assets (Operating ROA)
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 164,883 | 170,195 | 167,496 | 178,925 | 156,033 | 139,977 | 132,349 | 110,127 | 80,750 | 40,376 | 45,150 | 79,422 | 89,747 | 136,929 | 137,411 | 128,368 | 103,351 | 101,200 | 88,613 | 64,950 |
Total assets | US$ in thousands | 2,195,590 | 2,200,430 | 2,011,280 | 1,962,260 | 1,934,820 | 1,878,070 | 1,865,110 | 1,820,530 | 1,859,730 | 1,831,380 | 1,801,500 | 1,794,190 | 1,819,920 | 1,318,070 | 1,418,170 | 1,433,170 | 1,267,110 | 1,237,750 | 1,190,540 | 1,259,610 |
Operating ROA | 7.51% | 7.73% | 8.33% | 9.12% | 8.06% | 7.45% | 7.10% | 6.05% | 4.34% | 2.20% | 2.51% | 4.43% | 4.93% | 10.39% | 9.69% | 8.96% | 8.16% | 8.18% | 7.44% | 5.16% |
March 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $164,883K ÷ $2,195,590K
= 7.51%
Haemonetics Corporation's operating return on assets (operating ROA) has exhibited fluctuations over the past several quarters. The trend shows an improvement in performance from the fourth quarter of 2019 to the first quarter of 2020 with operating ROA increasing from 5.16% to 10.39%. This was followed by a gradual decline in the metric until the second quarter of 2021.
However, from the third quarter of 2021 onwards, there has been a significant uptrend in operating ROA, reaching a peak of 9.12% in the second quarter of 2023. Overall, the company's operating ROA has ranged from a low of 2.20% in the first quarter of 2022 to a high of 10.39% in the first quarter of 2020.
The recent values of operating ROA indicate relatively healthy profitability levels compared to previous periods, with the metric hovering around the 7-9% range. It is important for investors and stakeholders to monitor this ratio to assess the company's efficiency in generating profits from its assets over time.
Peer comparison
Mar 31, 2024